References
- Shane AL, Sánchez PJ, Stoll BJ. Neonatal sepsis. Lancet. 2017;390(10104):1770–1780. doi:10.1016/S0140-6736(17)31002-4
- Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med. 2018;6(3):223–230. doi:10.1016/s2213-2600(18)30063-8
- Procianoy RS, Silveira RC. The challenges of neonatal sepsis management. J Pediatr. 2020;96(Suppl 1):80–86. doi:10.1016/j.jped.2019.10.004
- Dong Y, Basmaci R, Titomanlio L, Sun B, Mercier JC. Neonatal sepsis: within and beyond China. Chin Med J. 2020;133(18):2219–2228. doi:10.1097/CM9.0000000000000935
- Wynn JL. Defining neonatal sepsis. Curr Opin Pediatr. 2016;28(2):135–140. doi:10.1097/MOP.0000000000000315
- Weiss SL, Peters MJ, Alhazzani W, et al. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med. 2020;46(Suppl 1):10–67. doi:10.1007/s00134-019-05878-6
- Zea-Vera A, Ochoa TJ. Challenges in the diagnosis and management of neonatal sepsis. J Trop Pediatr. 2015;61(1):1–13. doi:10.1093/tropej/fmu079
- Molloy EJ, Bearer CF. Paediatric and neonatal sepsis and inflammation. Pediatric Res. 2022;91(2):267–269. doi:10.1038/s41390-021-01918-4
- Vecchie A, Bonaventura A, Toldo S, Dagna L, Dinarello CA. Abbate A. IL-18 and infections: is there a role for targeted therapies? J Cell Physiol. 2021;236(3):1638–1657. doi:10.1002/jcp.30008
- Nanda JD, Ho TS, Satria RD, Jhan MK, Wang YT. Lin CF. IL-18: the forgotten cytokine in dengue immunopathogenesis. J Immunol Res. 2021;2021:8214656. doi:10.1155/2021/8214656
- Yasuda K, Nakanishi K, Tsutsui H. Interleukin-18 in health and disease. Int J Mol Sci. 2019;20(3):649. doi:10.3390/ijms20030649
- Nozaki Y, Hino S, Ri J, et al. Lipopolysaccharide-induced acute kidney injury is dependent on an IL-18 receptor signaling pathway. Int J Mol Sci. 2017;18(12):2777. doi:10.3390/ijms18122777
- Wang M, Markel TA, Meldrum DR. Interleukin 18 in the heart. Shock. 2008;30(1):3–10. doi:10.1097/SHK.0b013e318160f215
- Okuhara Y, Yokoe S, Iwasaku T, et al. Interleukin-18 gene deletion protects against sepsis-induced cardiac dysfunction by inhibiting PP2A activity. Int J Cardiol. 2017;243:396–403. doi:10.1016/j.ijcard.2017.04.082
- Zaki Mel S, Elgendy MY, El-Mashad NB. Farahat ME. IL-18 level correlates with development of sepsis in surgical patients. Immunol Invest. 2007;36(4):403–411. doi:10.1080/08820130701244275
- Feng M, Sun T, Zhao Y, Zhang H. Detection of serum interleukin-6/10/18 levels in sepsis and its clinical significance. J Clin Lab Anal. 2016;30(6):1037–1043. doi:10.1002/jcla.21977
- Barekatain B, HasanGhalyaei N, Mohammadizadeh M, Tavakolifard N. Investigation of salivary C-reactive protein and interleukin-18 for the diagnosis of neonatal sepsis. J Res Med Sci. 2021;26(1):131. doi:10.4103/jrms.JRMS_1256_20
- Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatric Critical Care Med. 2005;6(1):2–8. doi:10.1097/01.Pcc.0000149131.72248.E6
- Hughes G. Youden’s index and the weight of evidence. Methods Inf Med. 2015;54(2):198–199. doi:10.3414/ME14-04-0003
- Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin North Am. 2013;60(2):367–389. doi:10.1016/j.pcl.2012.12.003
- Iroh Tam PY, Bendel CM. Diagnostics for neonatal sepsis: current approaches and future directions. Pediatric Res. 2017;82(4):574–583. doi:10.1038/pr.2017.134
- Kaplanski G. Interleukin-18: biological properties and role in disease pathogenesis. Immunol Rev. 2018;281(1):138–153. doi:10.1111/imr.12616
- Sun RQ, Zhang SL. 脓毒症早期血清白细胞介素-18和10在疾病严重程度及预后评估中的价值研究 [The value of serum interleukin-18 and 10 in the evaluation of severity and prognosis in the early stage of sepsis]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011;23(5):299–301. Chinese.
- Zhang LM, Zhang J, Zhang Y, et al. Interleukin-18 binding protein attenuates lipopolysaccharide-induced acute lung injury in mice via suppression NF-kappaB and activation Nrf2 pathway. Biochem Biophys Res Commun. 2018;505(3):837–842. doi:10.1016/j.bbrc.2018.09.193
- Netea MG, Fantuzzi G, Kullberg BJ, et al. Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia. J Immunol. 2000;164(5):2644–2649. doi:10.4049/jimmunol.164.5.2644
- Raeburn CD, Dinarello CA, Zimmerman MA, et al. Neutralization of IL-18 attenuates lipopolysaccharide-induced myocardial dysfunction. Am J Physiol Heart Circ Physiol. 2002;283(2):H650–H657. doi:10.1152/ajpheart.00043.2002
- Wynn JL, Wilson CS, Hawiger J, et al. Targeting IL-17A attenuates neonatal sepsis mortality induced by IL-18. Proc Natl Acad Sci U S A. 2016;113(19):E2627–E2635. doi:10.1073/pnas.1515793113
- Kingsmore SF, Kennedy N, Halliday HL, et al. Identification of diagnostic biomarkers for infection in premature neonates. Mol Cell Proteomics. 2008;7(10):1863–1875. doi:10.1074/mcp.M800175-MCP200